CSL Signs Licensing Deal with Eli Lilly for Clazakizumab
18 Feb 2026 //
REUTERS
Sanofi points to long-term efficacy of Teva-partnered IBD drug
18 Feb 2026 //
PRESS RELEASE
Compass Pathways Hits Primary Endpoint In 2nd Phase 3 Trial
18 Feb 2026 //
PHARMIWEB
Bayer strikes $7.25B settlement, the latest turn in Roundup saga
18 Feb 2026 //
FIERCE PHARMA
Ocular`s Ophthalmologic Version of Inlyta bests Eylea in ph. 3
18 Feb 2026 //
FIERCE PHARMA
FDA Approves FILKRI, Accord BioPharma`s Biosimilar to NEUPOGEN
18 Feb 2026 //
PR NEWSWIRE
Janux Announces First Patient Dosed in Phase 1 Study of JANX011
18 Feb 2026 //
BUSINESSWIRE
Beyfortus study published in The Lancet Infectious Diseases
17 Feb 2026 //
PRESS RELEASE
FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad
17 Feb 2026 //
BIOSPACE
Drugs In Development
Market Intel

Market Place
Sourcing Support